Daiwa Securities Group Inc. increased its stake in Stryker Corp. (NYSE:SYK) by 6.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 51,600 shares of the medical technology company’s stock after buying an additional 3,300 shares during the period. Daiwa Securities Group Inc.’s holdings in Stryker Corp. were worth $6,007,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. LSV Asset Management purchased a new position in Stryker Corp. during the second quarter worth approximately $107,000. Global X Management Co. LLC boosted its position in Stryker Corp. by 235.8% in the second quarter. Global X Management Co. LLC now owns 994 shares of the medical technology company’s stock worth $119,000 after buying an additional 698 shares in the last quarter. Mycio Wealth Partners LLC purchased a new position in Stryker Corp. during the third quarter worth approximately $116,000. Carroll Financial Associates Inc. boosted its position in Stryker Corp. by 78.0% in the second quarter. Carroll Financial Associates Inc. now owns 1,086 shares of the medical technology company’s stock worth $130,000 after buying an additional 476 shares in the last quarter. Finally, Penserra Capital Management LLC boosted its position in Stryker Corp. by 100.0% in the third quarter. Penserra Capital Management LLC now owns 1,188 shares of the medical technology company’s stock worth $138,000 after buying an additional 594 shares in the last quarter. Hedge funds and other institutional investors own 74.90% of the company’s stock.

Institutional Ownership by Quarter for Stryker Corp. (NYSE:SYK)

Shares of Stryker Corp. (NYSE:SYK) traded down 1.52% during trading on Wednesday, reaching $113.66. 1,830,244 shares of the company were exchanged. The firm has a market capitalization of $42.56 billion, a PE ratio of 25.87 and a beta of 0.86. The company’s 50-day moving average is $113.51 and its 200 day moving average is $115.06. Stryker Corp. has a 1-year low of $86.68 and a 1-year high of $123.55.

Stryker Corp. (NYSE:SYK) last issued its quarterly earnings results on Thursday, October 27th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.37 by $0.02. The company had revenue of $2.83 billion for the quarter, compared to the consensus estimate of $2.81 billion. Stryker Corp. had a net margin of 15.24% and a return on equity of 23.61%. The firm’s revenue was up 17.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.25 EPS. Equities research analysts expect that Stryker Corp. will post $5.78 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Daiwa Securities Group Inc. Has $6,007,000 Position in Stryker Corp. (SYK)” was first posted by Daily Political and is owned by of Daily Political. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright laws. The correct version of this report can be accessed at http://www.dailypolitical.com/2016/11/30/daiwa-securities-group-inc-has-6007000-position-in-stryker-corp-syk.html.

A number of research firms recently commented on SYK. Canaccord Genuity set a $127.00 target price on Stryker Corp. and gave the company a “buy” rating in a research note on Sunday, October 30th. Oppenheimer Holdings Inc. set a $122.00 target price on Stryker Corp. and gave the company a “hold” rating in a research note on Sunday, October 30th. Zacks Investment Research cut Stryker Corp. from a “buy” rating to a “hold” rating in a research note on Monday, November 14th. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker Corp. in a research note on Sunday, November 13th. Finally, SunTrust Banks Inc. initiated coverage on Stryker Corp. in a research note on Thursday, October 13th. They set a “buy” rating and a $140.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $122.38.

In other news, Director Ronda E. Stryker sold 18,000 shares of the stock in a transaction that occurred on Tuesday, November 15th. The shares were sold at an average price of $109.53, for a total transaction of $1,971,540.00. Following the transaction, the director now directly owns 193,142 shares in the company, valued at $21,154,843.26. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Ronda E. Stryker sold 12,000 shares of the stock in a transaction that occurred on Monday, November 7th. The shares were sold at an average price of $118.22, for a total transaction of $1,418,640.00. Following the transaction, the director now owns 193,142 shares in the company, valued at $22,833,247.24. The disclosure for this sale can be found here. 7.80% of the stock is currently owned by company insiders.

About Stryker Corp.

Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties.

5 Day Chart for NYSE:SYK

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corp. (NYSE:SYK).

Receive News & Ratings for Stryker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corp. and related companies with MarketBeat.com's FREE daily email newsletter.